Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

被引:370
作者
Civeira, F [1 ]
机构
[1] Hosp Univ Miguel Servet, Lipid Unit, Zaragoza 50009, Spain
关键词
familial hypercholesterolemia; management; treatment; guidelines;
D O I
10.1016/j.atherosclerosis.2003.11.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism characterized by very high plasma concentrations of low density lipoprotein cholesterol (LDLc), tendon xanthomas and increased risk of premature coronary heart disease (CHD). FH is a public health problem throughout the world. There are 10,000,000 people with FH worldwide, mainly heterozygotes, and approximately 85% of males and 50% of females with FH will suffer a coronary event before 65 years old if appropriate preventive efforts are not implemented. Early identification of persons with FH and their relatives, and the early start of treatment are essential issues in the prevention of premature cardiovascular disease (CVD) and death in this population. However, guidelines for the general population formally exclude FH from their diagnostic and treatment recommendations. These guidelines have been elaborated by a group of international experts with the intention to answer the main questions about heterozygous FH (heFH) subjects that physicians worldwide face in the diagnosis and management of these patients. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:55 / 68
页数:14
相关论文
共 116 条
  • [1] Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease - The LDL-apheresis atherosclerosis regression study (LAARS)
    Aengevaeren, WRM
    Kroon, AA
    Stalenhoef, AFH
    Uijen, GJH
    vanderWerf, T
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (07) : 1696 - 1704
  • [2] Heterozygous familial hypercholesterolemia in Spain.: Description of 819 non related cases
    Alonso, R
    Castillo, S
    Civeira, F
    Puzo, J
    de la Cruz, JJ
    Pocoví, M
    Mata, P
    [J]. MEDICINA CLINICA, 2002, 118 (13): : 487 - 492
  • [3] Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin
    Alonso, R
    Mata, P
    De Andres, R
    Villacastin, BP
    Martínez-González, J
    Badimon, L
    [J]. ATHEROSCLEROSIS, 2001, 157 (02) : 423 - 429
  • [4] Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia
    Amundsen, ÅL
    Ose, L
    Nenseter, MS
    Ntanios, FY
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (02) : 338 - 344
  • [5] [Anonymous], 1993, Arch Intern Med, V153, P1321
  • [6] ARRUDA AM, 2001, J AM COLL CARDIOL, V37
  • [7] Assmann G, 1998, EUR HEART J, V19, pA2
  • [8] Low-density lipoprotein apheresis: Clinical results with different methods
    Bambauer, R
    [J]. ARTIFICIAL ORGANS, 2002, 26 (02) : 133 - 139
  • [9] Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia
    Baron, H
    Fung, S
    Aydin, A
    Bahring, S
    Luft, FC
    Schuster, H
    [J]. NATURE BIOTECHNOLOGY, 1996, 14 (10) : 1279 - 1282
  • [10] Coronary plaque regression: Role of low density lipoprotein-apheresis
    Barter, PJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (02) : 228 - 230